Whereas a number of large gaming firms have flirted with the concept of non-fungible tokens, none has embraced the crypto rip-off with as a lot blind confidence as Sq. Enix. Now the Last Fantasy maker has lastly revealed its first NFT stunt, Symbiogenesis, crushing fan hopes that the beforehand leaked title was truly for a long-awaited resurrection of cult-hit horror RPG Parasite Eve.
“NFT Collectible Artwork Undertaking SYMBIOGENESIS Untangle the Story Spring 2023,” Sq. Enix tweeted on Thursday. A brief teaser revealed the brand artwork alongside some upbeat digital jazz. Introduced on the Web3 Conclave occasion at India’s Sport Builders Convention, Symbiogenesis can be hosted on the Ethereum blockchain and allegedly inform a narrative about characters whose artwork gamers can personal as NFTs.
“The artwork can be utilized for social media profile photos (PFP) and as a personality in a narrative that takes place in an alternate world the place the participant can ’untangle’ a thriller by finishing missions that revolve round questions of the monopolization and distribution of assets,” a press launch reads. You possibly can’t make this up.
Whereas the beloved JRPG writer’s crypto ambitions are nothing new—the corporate introduced a Cloud Strife NFT as an costly collectible add-on earlier this yr—the Symbiogenesis reveal is hitting some followers particularly laborious as a result of they thought the title hinted on the return of Parasite Eve. The RPG thriller actually revolves across the symbiosis of a parasite and its host, and regardless of an excellent PS1 recreation and first rate sequel, the collection has been dormant since The third Birthday on the PSP again in 2010.
Immediately’s Sq. Enix tweet has already been roundly ratio’d, with Parasite Eve followers collectively shaking their heads in disbelief. However will it trigger the writer to lastly revaluate its plans and put the NFT cringe pipeline on maintain? Who can say. Sq. Enix is clearly having an id disaster of kinds for the time being.
This yr it bought bought its American studios behind Deus Ex and Tomb Raider, advised traders it was open to partial buyouts of its different studios, and flooded the market with a ton of JRPG sequels, remakes, and remasters, whereas barely giving any of them time to breathe or, apparently, a advertising and marketing price range. And now: Symbiogenesis.